RANDOMIZED TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) PLUS CARBOPLATIN VERSUS CARBOPLATIN IN PLATINUM-SENSITIVE (PS) PATIENTS WITH RECURRENT EPITHELIAL OVARIAN OR PERITONEAL CA...

Por Alberts, David S., Liu, P. Y., Wilczynski, Sharon P., Clouser, Mary C., Lopez, Ana Maria, Michelin, David P., Lanzotti, Victor J., Markman, Maurie
Publicado em 2007

SINGLE AGENT CARBOPLATIN VERSUS CARBOPLATIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN IN RECURRENT OVARIAN CANCER: FINAL SURVIVAL RESULTS OF A SWOG (S0200) PHASE 3 RANDOMIZED TRIAL

Por Markman, Maurie, Moon, James, Wilczynski, Sharon, Lopez, Ana Maria, Rowland, Kendrith M., Michelin, David P., Lanzotti, Victor J., Anderson, Garnet L., Alberts, David S.
Publicado em 2009

A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine

Por Parker, Patricia A, Urbauer, Diana, Fisch, Michael J, Fellman, Bryan, Hough, Holly, Miller, Jessica, Lanzotti, Victor, Whisnant, Mindy, Weiss, Matthias, Fellenz, Lori, Bury, Martin, Kokx, Patricia, Finn, Kathleen, Daily, Maureen, Cohen, Lorenzo
Publicado em 2013